Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS

Clinical trial NCT01764737 · COMPLETED

Trial details

NCT number: NCT01764737
Sponsor: Vaccinex Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2012-12-01
Primary completion: 2014-11-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.